OSCAR HEALTH INC

Company Overview

Oscar Health Inc. is a healthcare technology company operating in the Healthcare sector and Healthcare Plans industry, with a strong focus on the ACA individual market. It sells health plans to individuals, families, and employees through ICHRA arrangements, and its model combines insurance operations with a cloud-native technology platform that supports member engagement, claims management, billing, and benefits administration. The company also monetizes its technology through +Oscar, a data- and AI-driven platform sold to providers and payors. Recent filings show Oscar is growing membership quickly, but profitability has been pressured by rising medical costs, higher risk adjustment accruals, and regulatory changes affecting ACA enrollment and subsidies.

Executive Compensation Practices

For a company like Oscar, executive compensation is likely tied to a mix of growth and insurance-specific profitability metrics, rather than revenue alone. In addition to membership growth and premium revenue, pay plans would reasonably emphasize medical loss ratio (MLR), SG&A efficiency, operating income or adjusted EBITDA, cash flow, and capital/risk-based capital discipline, since those are the key levers in an ACA health plan business. Because Oscar’s results are sensitive to morbidity, risk adjustment, and enrollment seasonality, incentive plans may also include performance hurdles tied to forecast accuracy, claims management, and regulatory compliance. The company’s technology platform and expansion into +Oscar and ICHRA-related products may also influence long-term incentives by rewarding scalable growth and diversification beyond core insurance margins.

Insider Trading Considerations

Insider trading patterns at Oscar may be influenced by the company’s highly seasonal and regulation-sensitive business model. Executives and directors likely face heightened sensitivity around trading windows because membership, claims trends, and risk adjustment estimates can move quickly during and after open enrollment, SEP periods, and CMS reporting cycles. The stock may also react sharply to policy headlines such as ACA subsidy extensions, CMS program integrity rules, or changes in marketplace eligibility verification, making pre-earnings and pre-regulatory-update trading particularly important for researchers. Given Oscar’s exposure to medical cost trends, reserve estimates, and capital levels, insiders may be especially cautious about trading ahead of quarter-end disclosures when management has the most visibility into morbidity, utilization, and risk adjustment developments.